A controlled trial of cisapride in anorexia nervosa

George I. Szmukler, Graeme P. Young, Gladys Miller, Meir Lichtenstein, David S. Binns

Research output: Contribution to journalArticlepeer-review

55 Citations (Scopus)


To determine the efficacy of cisapride, 10 mg three times daily, in improving gastric emptying, reducing distress during meals, and facilitating weight gain in anorexia nervosa, we conducted an 8‐week, randomized, double‐blind, placebo‐controlled trial on 29 inpatients. Measures included scintigraphic gastric emptying studies at 0, 2, 4, and 8 weeks; subjective distress during meals measured by visual analogue scales; selfrating of degree of global improvement in symptoms associated with eating at end of study; and weight measured weekly. Gastric emptying improved significantly but equally in both groups over the study period. Yet subjective measures were better in the cisapride group; they rated themselves as more hungry (p = .02) and more improved on the global measure of change in symptoms (p = .02). Even so, the cisapride group did not gain more weight. The correlation between gastric emptying and weight gain was modest (r = .30; p = .11), and between gastric emptying and the subjective measures, virtually absent. © 1995 by John Wiley & Sons, Inc.

Original languageEnglish
Pages (from-to)347-357
Number of pages11
JournalInternational Journal of Eating Disorders
Issue number4
Publication statusPublished - May 1995
Externally publishedYes


Dive into the research topics of 'A controlled trial of cisapride in anorexia nervosa'. Together they form a unique fingerprint.

Cite this